N-benzyl-2-[(1R,13R,18S)-13-[(1-benzyltriazol-4-yl)methyl]-11,14-dioxo-4-oxa-6,12,15-triazatricyclo[13.3.1.05,10]nonadeca-5(10),6,8-trien-18-yl]acetamide

C34H37N7O4 — CID 146117312

IUPACN-benzyl-2-[(1R,13R,18S)-13-[(1-benzyltriazol-4-yl)methyl]-11,14-dioxo-4-oxa-6,12,15-triazatricyclo[13.3.1.05,10]nonadeca-5(10),6,8-trien-18-yl]acetamide
SMILESO=C(C[C@@H]1CCN2C[C@@H]1CCOc1ncccc1C(=O)N[C@H](Cc1cn(Cc3ccccc3)nn1)C2=O)NCc1ccccc1
InChIInChI=1S/C34H37N7O4/c42-31(36-20-24-8-3-1-4-9-24)18-26-13-16-40-22-27(26)14-17-45-33-29(12-7-15-35-33)32(43)37-30(34(40)44)19-28-23-41(39-38-28)21-25-10-5-2-6-11-25/h1-12,15,23,26-27,30H,13-14,16-22H2,(H,36,42)(H,37,43)/t26-,27-,30+/m0/s1
InChIKeyUFZQQCOJFOKPOG-FEVNIDIWSA-N
MW607.72 g/mol
LogP3.02
Rot. Bonds8

About N-benzyl-2-[(1R,13R,18S)-13-[(1-benzyltriazol-4-yl)methyl]-11,14-dioxo-4-oxa-6,12,15-triazatricyclo[13.3.1.05,10]nonadeca-5(10),6,8-trien-18-yl]acetamide

N-benzyl-2-[(1R,13R,18S)-13-[(1-benzyltriazol-4-yl)methyl]-11,14-dioxo-4-oxa-6,12,15-triazatricyclo[13.3.1.05,10]nonadeca-5(10),6,8-trien-18-yl]acetamide (PubChem CID 146117312) has the molecular formula C34H37N7O4 and a molecular weight of 607.72 g/mol. Its IUPAC name is N-benzyl-2-[(1R,13R,18S)-13-[(1-benzyltriazol-4-yl)methyl]-11,14-dioxo-4-oxa-6,12,15-triazatricyclo[13.3.1.05,10]nonadeca-5(10),6,8-trien-18-yl]acetamide.

Molecular Properties

Compound NameN-benzyl-2-[(1R,13R,18S)-13-[(1-benzyltriazol-4-yl)methyl]-11,14-dioxo-4-oxa-6,12,15-triazatricyclo[13.3.1.05,10]nonadeca-5(10),6,8-trien-18-yl]acetamide
PubChem CID146117312
Molecular FormulaC34H37N7O4
Molecular Weight607.72 g/mol
Exact Mass607.29
IUPAC NameN-benzyl-2-[(1R,13R,18S)-13-[(1-benzyltriazol-4-yl)methyl]-11,14-dioxo-4-oxa-6,12,15-triazatricyclo[13.3.1.05,10]nonadeca-5(10),6,8-trien-18-yl]acetamide
SMILESO=C(C[C@@H]1CCN2C[C@@H]1CCOc1ncccc1C(=O)N[C@H](Cc1cn(Cc3ccccc3)nn1)C2=O)NCc1ccccc1
InChIInChI=1S/C34H37N7O4/c42-31(36-20-24-8-3-1-4-9-24)18-26-13-16-40-22-27(26)14-17-45-33-29(12-7-15-35-33)32(43)37-30(34(40)44)19-28-23-41(39-38-28)21-25-10-5-2-6-11-25/h1-12,15,23,26-27,30H,13-14,16-22H2,(H,36,42)(H,37,43)/t26-,27-,30+/m0/s1
InChIKeyUFZQQCOJFOKPOG-FEVNIDIWSA-N
XLogP3.02
TPSA131.34 Ų
H-Bond Donors2
H-Bond Acceptors8
Rotatable Bonds8
Heavy Atoms45
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500607.72
LogP ≤ 53.02
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 108

Analyze N-benzyl-2-[(1R,13R,18S)-13-[(1-benzyltriazol-4-yl)methyl]-11,14-dioxo-4-oxa-6,12,15-triazatricyclo[13.3.1.05,10]nonadeca-5(10),6,8-trien-18-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-benzyl-2-[(1R,13R,18S)-13-[(1-benzyltriazol-4-yl)methyl]-11,14-dioxo-4-oxa-6,12,15-triazatricyclo[13.3.1.05,10]nonadeca-5(10),6,8-trien-18-yl]acetamide?
The IUPAC name of N-benzyl-2-[(1R,13R,18S)-13-[(1-benzyltriazol-4-yl)methyl]-11,14-dioxo-4-oxa-6,12,15-triazatricyclo[13.3.1.05,10]nonadeca-5(10),6,8-trien-18-yl]acetamide (CID 146117312) is N-benzyl-2-[(1R,13R,18S)-13-[(1-benzyltriazol-4-yl)methyl]-11,14-dioxo-4-oxa-6,12,15-triazatricyclo[13.3.1.05,10]nonadeca-5(10),6,8-trien-18-yl]acetamide.
What is the SMILES notation for N-benzyl-2-[(1R,13R,18S)-13-[(1-benzyltriazol-4-yl)methyl]-11,14-dioxo-4-oxa-6,12,15-triazatricyclo[13.3.1.05,10]nonadeca-5(10),6,8-trien-18-yl]acetamide?
The canonical SMILES for N-benzyl-2-[(1R,13R,18S)-13-[(1-benzyltriazol-4-yl)methyl]-11,14-dioxo-4-oxa-6,12,15-triazatricyclo[13.3.1.05,10]nonadeca-5(10),6,8-trien-18-yl]acetamide is O=C(C[C@@H]1CCN2C[C@@H]1CCOc1ncccc1C(=O)N[C@H](Cc1cn(Cc3ccccc3)nn1)C2=O)NCc1ccccc1.
What is the InChIKey of N-benzyl-2-[(1R,13R,18S)-13-[(1-benzyltriazol-4-yl)methyl]-11,14-dioxo-4-oxa-6,12,15-triazatricyclo[13.3.1.05,10]nonadeca-5(10),6,8-trien-18-yl]acetamide?
The InChIKey is UFZQQCOJFOKPOG-FEVNIDIWSA-N. The full InChI is InChI=1S/C34H37N7O4/c42-31(36-20-24-8-3-1-4-9-24)18-26-13-16-40-22-27(26)14-17-45-33-29(12-7-15-35-33)32(43)37-30(34(40)44)19-28-23-41(39-38-28)21-25-10-5-2-6-11-25/h1-12,15,23,26-27,30H,13-14,16-22H2,(H,36,42)(H,37,43)/t26-,27-,30+/m0/s1.
What are the key properties of N-benzyl-2-[(1R,13R,18S)-13-[(1-benzyltriazol-4-yl)methyl]-11,14-dioxo-4-oxa-6,12,15-triazatricyclo[13.3.1.05,10]nonadeca-5(10),6,8-trien-18-yl]acetamide?
N-benzyl-2-[(1R,13R,18S)-13-[(1-benzyltriazol-4-yl)methyl]-11,14-dioxo-4-oxa-6,12,15-triazatricyclo[13.3.1.05,10]nonadeca-5(10),6,8-trien-18-yl]acetamide has a molecular weight of 607.72 g/mol, XLogP of 3.02, 8 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-benzyl-2-[(1R,13R,18S)-13-[(1-benzyltriazol-4-yl)methyl]-11,14-dioxo-4-oxa-6,12,15-triazatricyclo[13.3.1.05,10]nonadeca-5(10),6,8-trien-18-yl]acetamide is sourced from PubChem (CID 146117312), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).